Filing Details
- Accession Number:
- 0001237899-15-000053
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-11-04 16:05:12
- Reporting Period:
- 2015-11-02
- Filing Date:
- 2015-11-04
- Accepted Time:
- 2015-11-04 16:05:12
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 872589 | Regeneron Pharmaceuticals Inc | REGN | Pharmaceutical Preparations (2834) | 133444607 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1013064 | Roy P Vagelos | 777 Old Saw Mill River Road Tarrytown NY 10591 | Chairman Of The Board | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2015-11-02 | 13,257 | $580.18 | 355,836 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2015-11-03 | 3,985 | $580.23 | 351,851 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2015-01-06 | 511 | $0.00 | 155,266 | No | 5 | G | Indirect | by CLAT |
| Common Stock | Disposition | 2015-04-01 | 462 | $0.00 | 154,804 | No | 5 | G | Indirect | by CLAT |
| Common Stock | Disposition | 2015-07-01 | 414 | $0.00 | 154,390 | No | 5 | G | Indirect | by CLAT |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 5 | G | Indirect | by CLAT |
| No | 5 | G | Indirect | by CLAT |
| No | 5 | G | Indirect | by CLAT |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 2,282 | Indirect | By 401(k) Plan |
| Common Stock | 92,947 | Indirect | by Spouse as Trustee |
| Common Stock | 1,203 | Indirect | by trust for grandch |
Footnotes
- Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
- Represents volume-weighted average price of sales of 13,257 shares of Company stock on November 2, 2015 at prices ranging from $580.00 to $580.92. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 2, 2015 at each separate price.
- Represents volume-weighted average price of sales of 3,985 shares of Company stock on November 3, 2015 at prices ranging from $580.00 to $580.52. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 3, 2015 at each separate price.
- By a trust for the benefit of certain grandchildren of the reporting person, of which the reporting person and/or the spouse of the reporting person is trustee.
Billionaire Hedge Funds
